FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

OncoCalendar

Loading Events

« All Events

  • This event has passed.

ESMO in Focus Webinar – Upper Gastrointestinal Cancer 2025

Sep 23
esmo

The ESMO in Focus Webinar – Upper Gastrointestinal Cancer 2025 will be held in September 23, 2025. This webinar provides an expert overview and discussion of the latest developments in the management of patients with upper gastrointestinal cancers. It focuses on recent advancements in treatment approaches, research findings, and clinical practice updates to optimize patient care in upper GI oncology.

The webinar is part of the ESMO webinar series, designed to bring oncology professionals up-to-date knowledge on specific cancer types, concentrating on emerging data and controversies in the field. The session offers insights from leading experts and serves to deepen understanding beyond standard guidelines, covering tumor biology, novel therapies, and areas of unmet need in upper gastrointestinal cancers.

Register Here.